President Donald Trump has reportedly proposed a new policy that would prohibit any company that markets or sells a drug in the U.S. from trademarking any word or phrase that can be associated with that drug.
The White House did not respond to a request for comment.
Trump’s proposal is the latest development in a fight over drug-related trademarks that has spanned the last decade.
In 2015, the U,S.
Supreme Court ruled that drug companies cannot use trademarks to trademark the name “Pentobarbital” for a drug that is a painkiller.
But drug makers have argued that they can’t be sued for using a generic name for a brand-name drug, and the U.,S.
Patent and Trademark Office issued a series of rulings in favor of drug makers.
The U.K. government is seeking to ban a company that manufactures a drug called “Clinox” from trademarkting the word “Clint,” a name used by the drug company to brand itself.
The drug company has been trying to avoid a trademark ban by suing the U.’s High Court, which has refused to hear the case.